200: Why 2024 is a make-or-break year for corporate medical groups
In this episode, host Rae Woods invites Advisory Board physician experts Sarah Roller and Eliza Dailey to discuss why 2024 will be a make-or-break year for corporate medical groups, and what that means for the rest of the industry.
Audio is streamed directly from the publisher (aphid.fireside.fm) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
In the last five years, the health care industry has seen an explosion of corporate ownership over medical groups. It's been relatively smooth sailing for many of these groups so far—but in 2024, they may face the same challenges as incumbents.
In this episode, host Rachel (Rae) Woods invites Advisory Board physician experts Sarah Roller and Eliza Dailey to discuss why 2024 will be a make-or-break year for corporate medical groups, and what that means for the rest of the industry.
Links:
- Bold predictions for healthcare in 2024
- What you need to know about rising medical group consolidation
- Physician employment is changing. What does that mean for the industry?
- Ep. 198: PE firm General Catalyst is buying a hospital — here's our take
Use Advisory Board's Clinician Supply Profiler to see how physician supply in your market compares to others.
Register for Advisory Board's Clinical Innovation Summit and learn about sponsorship opportunities.
Learn more about Advisory Board Fellowship.
A transcript of this episode as well as more information and resources can be found on radioadvisory.advisory.com.